Drs. Michael Bernstein and Lauren Micalizzi (MPIs) received funding in the form of a Research Excellence Award for their study, "Precision Medicine and Open-Label Placebo (OLP): Do Genes Moderate OLP Effects?" to examine genomic predictors of open label placebos for pain among patients with upper or lower extremity fractures.

Co-investigator: Dr. McGeary.